ALAMO GROUP INC (ALG)
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Industrials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ALG
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALG | Director; President & CEO | 58 | ["Executive leadership experience in both private and public companies","Experience successfully merging and integrating businesses","Completing strategic acquisitions","Identifying and leading divestitures","Cultivating a company culture focused on innovation, performance, and quality","Proven track record of scaling complex businesses","Driving operational excellence","Delivering sustained shareholder value"] | ["Audit Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Robert P. Hureau was appointed President and Chief Executive Officer of the Company in September 2025. He was appointed as a director of the Company at that time as well. Mr. Hureau previously held several executive level and director positions. From April 2019 to March 2025, Mr. Hureau served as Chief Executive Officer and as a director of American Trailer World ( ATW ), an industrial manufacturer and retailer of trailers, truck equipment and after-market parts. From January 2018 to April 2019, he served as ATW s EVP and Chief Financial Officer. Mr. Hureau served as the Chairman of the Board of ATW from March 2025 to February 2026. From February 2021 to January 2024, Mr. Hureau was a director of USLBM, the largest privately-owned, full-line distributor of specialty home building materials in the United States. He was also the Chair of USLBM s Audit Committee during that period of time. From September 2014 to January 2018, Mr. Hureau served as the EVP and Chief Financial Officer for Pharmaceutical Product Development ( PPD ), a global clinical research organization. From April 2013 to September 2014, Mr. Hureau served as the EVP and Chief Financial Officer of Acelity, a global medical technology company focused on advanced wound care and regenerative medicine. From February 2007 to April 2013, Mr. Hureau held several executive level positions at Sensata Technologies, including SVP and Chief Financial Officer from 2011 to April 2013. Sensata Technologies is a publicly traded, global industrial manufacturer of sensors and controls. In addition to his business experience, Mr. Hureau served on various advisory boards for ALSAC, the fundraising and awareness organization for St. Jude Children s Research Hospital, from 2014 to 2026. Mr. Hureau brings to the Company and Board several decades of executive leadership experience in both private and public companies. Mr. Hureau has experience successfully merging and integrating businesses, completing strategic acquisitions, and identifying and leading divestitures. His experience involves cultivating a company culture focused on innovation, performance, and quality. He brings to the Company and Board a proven track record of scaling complex businesses, driving operational excellence, and delivering sustained shareholder value.